Prostate and Urologic Cancers DART

Faculty Members:

• Maintain and increase our international leadership of clinical trials of transformative therapeutics in prostate and bladder cancer
• Provide state-of-the-art diagnostic and surveillance imaging modalities
• Increase our molecular translational research program impact through collaborations within Yale and with the broader research community
• Compete for bladder SPORE/program project grants within 4 years
• Extend and improve patients’ lives through collaborative and personalized treatment decisions

Goals for 2016:
1. Increase patient accrual by ≥25%
2. Open 9 new trials to accrual
3. Secure T-TARE funding for bladder cancer program to enable progression toward R01 and SPORE grant application

GU Tumor Board: Mondays at 12:00pm
Translational Research Meetings: Fourth Tuesday at 1:00pm